SHANGHAI SHYNDEC PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 600420 for the last quarter is 2.61 B CNY, and it's 7.07% lower compared to the previous quarter. The net income of Q3 24 is 236.05 M CNY.